INTRODUCTION
============

Elevated blood concentrations of low-density lipoprotein cholesterol (LDL-C) are associated with increased risk of coronary heart disease. Although lowering LDL-C concentrations can reduce cardiovascular morbidity and mortality, hyperlipidemia is underdiagnosed and undertreated.[@nux030-B1] A 10% increase in the prevalence of treatment for hyperlipidemia could prevent an estimated 8000 deaths per year.[@nux030-B2] It has been further estimated that even modest steps, such as those proposed by the National Cholesterol Education Program Adult Treatment Panel 3 primary prevention guidelines, could prevent approximately 20 000 heart attacks and 10 000 deaths due to coronary heart disease and save almost \$3 billion in heart disease-related medical costs per year.[@nux030-B3] Although LDL-C has been the primary lipoprotein of concern, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and triglycerides also play roles in heart disease risk, with TC, LDL-C, and triglycerides positively associated with risk and HDL-C possibly playing a protective role.[@nux030-B4] Here, "plasma lipids" refers to the group of lipids including TC, LDL-C, HDL-C, and triglycerides.

Modifiable factors, including diet, weight, and exercise, may play significant roles in developing hyperlipidemia.[@nux030-B5] Vegetarian diets are defined as diets that exclude meats; some vegetarian diets include dairy products and eggs. Vegetarian diets usually emphasize the consumption of fruits, vegetables, beans, and grains. Previous reviews have suggested that vegetarian diets are associated with lower plasma lipid concentrations.[@nux030-B6]^,^[@nux030-B7] Although a recent meta-analysis of randomized controlled trials showed that adoption of a vegetarian diet reduces plasma lipids, long-term effects of vegetarian diets were not studied. To the best of knowledge, the association between vegetarian diets and long-term effects on plasma lipids has not been subjected to meta-analysis. Therefore, a meta-analysis of studies that have examined vegetarian diets' relationship on plasma lipid concentrations was performed.

METHODS
=======

Data sources and search strategy
--------------------------------

The search strategy is shown in [Table S1](#sup1){ref-type="supplementary-material"} in the Supporting Information online. The electronic databases MEDLINE, Web of Science, and the Cochrane Central Register of Controlled Trials were searched for English-language articles published from 1946 to June 2015, from 1900 to June 2015, and from 1966 to June 2015, respectively, and containing one or more of the keywords for vegetarian diets ("plant-based diet" or "diet, vegetarian" or "vegetarian diets" or "vegetarianism" or "diets vegan" or "vegan diets") and for plasma lipids ("hyperlipidemia" or "cholesterol" or "low-density lipoprotein" or "high-density lipoprotein" or "triglyceride"). The reference lists of the retrieved articles were then reviewed to identify additional articles. This review was registered with the PROSPERO register of systematic reviews (registration no. CRD42015023783) and was conducted in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.

Study selection
---------------

Two reviewers (Y.Y. and S.M.L.) separately searched and retrieved abstracts for articles that met the following inclusion criteria: (1) participants aged over 20 years; (2) an intervention or exposure consisting of a vegetarian diet, defined as a diet that included meat less than once per month; a semivegetarian diet, defined as a diet that included meat more than once per month, but less than once per week; a vegan diet, defined as a diet that excluded all animal products; or a vegetarian diet that included some animal products as defined by the terms "lacto" (dairy products), "ovo" (eggs), or "pesco" (fish); (3) the collection of sufficient data to allow calculation of mean differences in total or LDL-C between participants who consumed a vegetarian diet and those who consumed a control diet; and (4) the use of a controlled trial or observational study design. The following exclusion criteria were applied: (1) article not an original paper; (2) lack of a comparison diet; (3) lack of continuous lipid data; (4) use of a duplicate sample; (5) small sample size (\< 10); (6) animal studies; (7) trial duration of \< 4 weeks; (8) article not in English; and (9) for observational studies, failure to adjust for sex and age. The PICOS (Participants, Intervention, Comparators, Outcomes, Study Design) criteria are shown in [Table 1](#nux030-T1){ref-type="table"}.[@nux030-B10]Table 1PICOS criteria for inclusion and exclusion of studiesParameterCriteriaPopulationAdult humans, without regard to sex, race, or ethnicityIntervention or exposureVegetarian or vegan dietsComparatorBasis for comparison was preintervention total cholesterol, LDL-C, HDL-C, and triglyceride concentrations in the intervention group or the corresponding changes in an untreated comparison group, if availableOutcomePrimary outcomes: changes in LDL-CSecondary outcomes: changes in HDL-C, total cholesterol, triglyceridesStudy designControlled trial or observational study design[^1]

Data extraction and quality assessment
--------------------------------------

For each study, the following information was extracted: study methodology and sample size; baseline characteristics of the study population, including mean age, sex (proportion of men), use of antihyperlipidemic drugs, body mass index (BMI); diets examined and duration of their consumption; concentrations and variance measures of plasma lipids, including those measured in response to dietary interventions in clinical trials; adjustment factors for observational studies, and Jadad score for clinical trials.

Data synthesis and analysis
---------------------------

Mean differences in concentrations of plasma lipids (TC, LDL-C, HDL-C, triglycerides) between vegetarian and comparison diet groups were calculated. For intervention trials, the pooled standard error for the net difference in lipid concentrations was used or, when it was not given, estimated using the method of Follmann et al,[@nux030-B8] assuming a correlation of 0.50 between the baseline and final plasma lipids values (parallel design) or between the intervention and the control period (crossover design) plasma lipid values. For studies comparing more than one exposure group or treatment arm, data were extracted from groups eating the fewest animal products, as this was deemed the best means of assessing the effects of vegetarian diets.

Using a random-effects model, which assigns a weight to each study on the basis of the study's inverse variance, estimates of differences in plasma lipids associated with consumption of vegetarian diets were combined. Using the study as the unit of analysis, estimates were obtained for observational studies and controlled trials separately. Estimates of plasma lipid differences were presented as means and 95%CIs. Statistical significance was set to 2-sided *P* values \< 0.05. Although triglyceride concentrations typically do not follow a normal distribution, inverse variances were calculated from original data because a previous simulation study showed that results were consistent across a range of underlying effect size distributions.[@nux030-B9]

Analyses stratified by type of vegetarian diet, country, sample size, age, sex, BMI, duration of diet, antihyperlipidemic medication use, and baseline lipid status were conducted separately for controlled trials and observational studies. A sensitivity analysis to assess the impact of each study on the combined effect was conducted by performing a 1-study removed analysis. To assess heterogeneity, calculations of *I*^2^ and meta-regression were done with subgroups, using the study as the unit of analysis.

To identify publication bias, funnel plots were created and examined, and to assess the relationship between sample size and effect size, Egger's test was performed. The "trim and fill" method, which determines where missing studies are likely to appear, was used to adjust for publication bias. These analyses were done separately for controlled trials and observational studies and were conducted for the main outcomes of TC and LDL-C. All analyses were performed using Comprehensive Meta-Analysis, version 2 software (BioStat, Englewood, NJ, USA).

RESULTS
=======

Search results
--------------

The search strategy led to the retrieval of 8385 studies, of which 30 observational studies[@nux030-B10] and 19 clinical trials[@nux030-B40] met the inclusion criteria ([Figure 1](#nux030-F1){ref-type="fig"}).

![**Flow diagram of the literature search process.** *Abbreviations*: LDL-C, low-density lipoprotein cholesterol; Obs, observational study.](nux030f1){#nux030-F1}

Study characteristics and quality
---------------------------------

### Observational studies.

The 30 observational studies ([Table 2](#nux030-T2){ref-type="table"}[@nux030-B40]) included 10 143 participants (median sample size, 74.5; range, 13--3424) with a mean age of 40.6 years (range, 23.8--71.8 years). Each of the 30 observational studies used a cross-sectional design. In 23 of these studies, participants had been following vegetarian diets for more than 1 year.[@nux030-B10]^,^[@nux030-B14]^,^[@nux030-B22]^,^[@nux030-B26]^,^[@nux030-B38] Eight studies focused on vegan diets,[@nux030-B11]^,^[@nux030-B23]^,^[@nux030-B24]^,^[@nux030-B29]^,^[@nux030-B32]^,^[@nux030-B33]^,^[@nux030-B35]^,^[@nux030-B38] 12 on lacto-ovo-vegetarian diets,[@nux030-B15]^,^[@nux030-B17]^,^[@nux030-B19]^,^[@nux030-B21]^,^[@nux030-B25]^,^[@nux030-B30]^,^[@nux030-B31]^,^[@nux030-B37]^,^[@nux030-B39] and 10 on mixed diet types (vegan, lacto, lacto-ovo, pesco, and/or semivegetarian).[@nux030-B10]^,^[@nux030-B12]^,^[@nux030-B16]^,^[@nux030-B18]^,^[@nux030-B20]^,^[@nux030-B22]^,^[@nux030-B34]^,^[@nux030-B36] The matched or adjusted factors in each study are shown in [Table 2](#nux030-T2){ref-type="table"}. Table 2Study design and population characteristics of observational studies of plant-based diets and plasma lipidsReference, countryStudy designMatched factors*N*Mean age (y)Percent maleMean BMI (kg/m^2^) or mean weight (kg)Mean baseline plasma lipids (mg/dL)Percent using medicationDuration of vegetarian dietsExposureControlComorbiditiesTCLDL-CHDL-CTGSacks et al (1975),[@nux030-B10] USACSAge, sex23044.062.965.5 kg155.095.546.072.5Strongly discouraged using medication38 moPescoOmnivorousBurslem et al (1978),[@nux030-B11] USACSAge, sex13427.337.0NR161.6103.345.985.405.2 yVeganOmnivorousNo metabolic diseases  Male, 20--30 yCSAge, sex4520--30100NR161.7103.343.890.105.2 yVeganOmnivorousNo metabolic diseases  Female, 20--30 yCSAge, sex5620--300.0NR156.499.947.081.405.2 yVeganOmnivorousNo metabolic diseases  Male, 30--40 yCSAge, sex1530--40100NR164.5102.343.394.305.2 yVeganOmnivorousNo metabolic diseases  Female, 30--40 yCSAge, sex1830--400.0NR175.1114.850.178.305.2 yVeganOmnivorousNo metabolic diseasesHuijbregts et al (1980),[@nux030-B39] the NetherlandsCSAge, sex, weight1418--2610069.9 kg176.9106.555.3100.1NRNRLacto-ovoOmnivorousHealthyNestel et al (1981),[@nux030-B37] AustraliaCSAge, sex, weight1328.510063.9 kg163.1103.641.8100.4NRNRLacto-ovoOmnivorousNRKnuiman & West (1982),[@nux030-B23] the NetherlandsCSAge, sex2733.810023.0172.398.142.9NRNR4 yVeganOmnivorousNRLiebman & Bazzarre (1983),[@nux030-B21] USACSAge, sex, height, weight, exercise level, alcohol consumption, smoking5430.710023.3187.0120.043.785.30\> 6 moLacto-ovoOmnivorousNo hyperlipidemia, CHD, angina, hypertension, or diabetesRoshanai & Sanders (1984),[@nux030-B24] UKCSAge, sex47NR48.922.0151.687.152.958.3NRNRVeganOmnivorousNR  Male23NR10023.0159.296.151.260.1  Female24NR0.021.0144.278.554.556.7Fisher et al (1986),[@nux030-B12] USACSAge, sex5020--4744.0NR156.5105.345.596.0NRVegan 9 y; lacto-ovo 7.7 yVegan/lacto-ovoOmnivorousNRNieman et al (1989),[@nux030-B30] USACSAge, sex, religion3771.80.023.3229.1139.564.6123.5047 yLacto-ovoOmnivorous (low fat)No stroke, hypertension, diabetes, cancer, or CHDSanders & Roshanai (1992),[@nux030-B29] UKCSAge, sex4032.350.021.9157.090.454.461.3012 yVeganOmnivorousHealthy (not receiving any treatment)  Male2032.510022.7160.396.551.262.4  Female2032.00.021.2153.784.357.660.2Krajcovicova-Kudlackova et al (1994),[@nux030-B34] SlovakiaCSAge, sex, geographical region10923.850.521.7183.0111.951.399.9NRMales 2.4 y; females 2.8 yLacto-ovo/lactoOmnivorousHealthy  Male5524.010022.6185.5114.450.8102.6  Female5423.60.020.7180.3109.451.897.2Harman & Parnell (1998),[@nux030-B13] New ZealandCSAge, sex4742.848.924.9196.1127.449.499.5NRNRLacto/veganOmnivorousNR  Male2344.710025.2197.0129.346.4106.3  Female2441.00.024.7195.3125.752.293.0Li et al (1999),[@nux030-B25] AustraliaCSSex7425.30.022.5166.091.959.984.0NR\> 6 moLacto-ovoOmnivorousHealthyRichter et al (1999),[@nux030-B28] GermanyCSAge, sex9536.437.5NR200.5124.951.8109.9NR\> 2 yLacto-ovoOmnivorousNo diabetes, gout, hypo- or hyperthyreosis, or disease of liver and kidney  Male3742.0100NR205.0129.946.4130.5  Female5833.00.0NR197.7121.755.296.8Lee et al (2000),[@nux030-B15] Hong KongCSAge, sex, BMI19340.036.823.7183.2113.649.695.2NR\> 1 yLacto-ovoOmnivorousHealthyLu et al (2000),[@nux030-B16] TaiwanCSAge, sex10938.648.621.5171.9109.450.783.6NR\> 2 yVegan/lactoOmnivorousNo liver disease, diabetes, or hypertension  Male5338.010021.9169.0113.143.488.6  Female5639.20.021.2171.5103.956.777.3Lin et al (2001),[@nux030-B27] TaiwanCSAge, sex4057.550.024.0164.0118.047.097.00\> 1 yLacto-ovoOmnivorousNo hypertension, diabetes, hyperlipoproteinemia, or overt vascular diseaseGoff et al (2005),[@nux030-B35] UKCSAge, sex, BMI4635.546.923.1153.788.149.379.40\> 3 yVeganOmnivorousNo diabetes, CHD, or metabolic disorderFu et al (2008),[@nux030-B17] TaiwanCSAge, sex7055.10.023.3188.8123.849.978.10\> 2 y (mean, 7.9 y)Lacto-ovoOmnivorousHealthyTeixeira et al (2007),[@nux030-B14] BrazilCSAge, sex, ethnicity, socioeconomic class20147.047.825.3207.7136.045.5141.7NR\> 5 y (mean, 19 y)Lacto-ovo/ vegan/pesco/ lactoOmnivorousKarabudak et al (2008),[@nux030-B36] TurkeyCSAge, sex, BMI5228.20.021.7164.388.954.188.60\> 2 ySemi-/lacto-ovo/lactoOmnivorousHealthyChen et al (2011),[@nux030-B31] TaiwanCSSex36351.90.023.1187.0122.559.090.50\> 1 yLacto-ovoOmnivorousNo diabetes, dyslipidemia, hypertension, cerebrovascular disease, chronic gingivitis, connective tissue disease, coronary artery disease, or feverFernandes Dourado et al (2011),[@nux030-B26] BrazilCSAge, sex8740.058.624.3191.4125.041.6127.30\> 1 y (mean, 16 y)Lacto-ovoOmnivorousNo temporary or permanent physical impairments or chronic disease in those who took medications that might influence the lipid profileYang et al (2011),[@nux030-B19] ChinaCSAge, sex30033.310023.9177.2108.845.1109.6NR\> 1 y (mean, 10.4 y)Lacto-ovoOmnivorousNo renal disease, cancer, diabetes, heart disease, or hypertensionKim et al (2012),[@nux030-B18] KoreaCSAge, sex7549.250.722.6181.5109.148.7123.80\> 15 y (mean, 24.6 y)Vegan/lacto-ovoOmnivorousHealthyGojda et al (2013),[@nux030-B38] Czech RepublicCSAge, sex, BMI, ethnicity, physical activity, energy intake2128.457.122.7147.877.558.560.50\> 3 y (mean, 8.05 y)VeganOmnivorousHealthyJung et al (2013),[@nux030-B20] KoreaCSAge, sex29652.953.424.1207.0131.755.2141.6NRNRVegan/lacto/ovo/lacto-ovoOmnivorousMetabolic syndrome (vegetarian, 30.4%, control, 17.6%)Chiang et al (2013),[@nux030-B22] TaiwanCSAge, sex70656.40.023.3189.9123.757.2107.20.4 \>1 yLacto-ovo/lacto/ovo/veganOmnivorousNo systemic diseases such as cancer, heart failure, uremia, and liver cirrhosis or acute illness such as acute myocardial infarctionHuang et al (2014),[@nux030-B32] TaiwanCSSex, pre- or postmenopausal342443.20.0NR184.5114.659.2111.90\> 1 yVeganOmnivorousNRJian et al (2015),[@nux030-B33] TaiwanCSSex318943.4100NR181.5116.251.5141.80\> 1 yVeganOmnivorousNR[^2]

### Clinical trials.

Nineteen clinical trials were identified ([Table 3](#nux030-T3){ref-type="table"}). These trials included a total of 1484 participants (median sample size = 58; range, 11--291) with a mean age of 48.6 years (range, 21--65 years). All were open (nonmasked) trials. The mean duration was 25.5 weeks. Eighteen were randomized controlled trials.[@nux030-B40]^,^[@nux030-B52] Vegan diets were examined in 9,[@nux030-B41]^,^[@nux030-B45]^,^[@nux030-B49]^,^[@nux030-B51] lacto-vegetarian diets in 2,[@nux030-B40]^,^[@nux030-B48] and lacto-ovo-vegetarian diets in 8.[@nux030-B42]^,^[@nux030-B50]^,^[@nux030-B55] Fourteen studies used a parallel design,[@nux030-B41]^,^[@nux030-B46]^,^[@nux030-B48]^,^[@nux030-B57]^,^[@nux030-B58] while 5 used a crossover design.[@nux030-B40]^,^[@nux030-B44]^,^[@nux030-B45]^,^[@nux030-B47]^,^[@nux030-B56] Baseline plasma lipid concentrations for each trial are shown in [Table 3](#nux030-T3){ref-type="table"}. Table 3Study design and population characteristics of clinical trials of plant-based diets and plasma lipidsReference, countryStudy design and durationJadad score*N*Mean age (y)Percent maleMean BMI (kg/m^2^)Mean baseline plasma lipids (mg/dL)Medication useIntervention dietControl dietComorbiditiesTCLDL-CHDL-CTGKestin et al (1989),[@nux030-B44] AustraliaRCT (CO), 6 wk22644.010025.5234.7157.856.5113.4NoneLacto-ovoOmnivorousNot on hyperlipoproteinemia or hypertension medicationLing et al (1992),[@nux030-B54] FinlandRCT (PL), 4 wk21842.822.226.6213.3141.550.1102.3NRVeganOmnivorous2 coronary heart disease, 1 obesity, 1 hypertensionOrnish et al (1998),[@nux030-B42] USARCT (PL), 48 wk33559.391.427.1234.9153.545.3225.9NoneOrnish (low-fat lacto-ovo)OmnivorousCoronary heart diseaseNicholson et al (1999),[@nux030-B53] USARCT (PL), 12 wk21154.354.5NR207.6NR44.0193.236.4 %Low-fat veganOmnivorousNon--insulin-dependent diabetes mellitusBarnard et al (2000),[@nux030-B45] USARCT (CO), 8 wk33536.1025.5163.097.049.081.0NoneLow-fat veganOmnivorousHealthy premenopausal womenAgren et al (2001),[@nux030-B46] FinlandRCT (PL), 12 wk22950.83.424.3190.3126.845.589.7NoneVeganOmnivorousRheumatoid arthritisDansinger et al (2005),[@nux030-B58] USARCT (PL), 48 wk38049.050.035.0217.5139.046.0164.0Mean of 2.4 medications per personOrnish (low-fat lacto-ovo)Calorie restrictionPresence of at least 1 of the metabolic cardiac risk factorsGardner et al (2005),[@nux030-B43] USARCT (PL), 4 wk312048.550.026.5224.3148.948.3128.5NoneLacto-ovoOmnivorous (low-fat)No heart disease or diabetesde Mello et al (2006),[@nux030-B40] BrazilRCT (CO), 4 wk21759.082.426.2206.5132.345.2139.1NoneLacto (low-protein)OmnivorousT2DAldana et al (2007),[@nux030-B55] USARCT (PL), 48 wk29361.656.331.0170.295.443.4157.1Yes, unknown percentageOrnish (low-fat lacto-ovo)OmnivorousCoronary heart diseaseBurke et al (2007),[@nux030-B50] USARCT (PL), 72 wk217644.013.134.0204.0NRNR134.0NoneLacto-ovo (calorie- and fat-restricted)Omnivorous (calorie- and fat-restricted)Overweight and obeseGardner et al (2007),[@nux030-B57] USARCT (PL), 48 wk215541.00.031.5NR107.450.5118.5NoneOrnish (low-fat lacto-ovo)Calorie restrictionOverweight in premenopauseElkan et al (2008),[@nux030-B41] SwedenRCT (PL), 12 wk25850.310.324.0191.7118.152.397.4NoneVeganOmnivorousRheumatoid arthritisBarnard et al (2009),[@nux030-B49] USARCT (PL), 74 wk39955.639.434.9193.0111.151.0153.254.5 %Low-fat veganADA dietT2DMiller et al (2009),[@nux030-B56] USARCT (CO), 4 wk21830.650.022.6184.9107.262.278.1NoneOrnish (low-fat lacto-ovo)Mediterranean South BeachHealthy (no history of metabolic, hepatic, renal, or systemic disease)Ferdowsian et al (2010),[@nux030-B51] USACT (PL), 22 wk110721--6517.7NR186.5105.451.8147.2Yes, unknown percentageLow-fat veganOmnivorousBMI ≥ 25 and/or T2DKahleova et al (2013),[@nux030-B48] Czech RepublicRCT (PL), 24 wk27456.247.335.1166.398.841.8186.051.4 %LactoEASD dietT2DMishra et al (2013),[@nux030-B52] USARCT (PL), 18 wk329145.217.235.0187.6108.255.2121.4NRLow-fat veganOmnivorousBMI ≥ 25 and/or T2DBunner et al (2014),[@nux030-B47] USARCT (CO), 16 wk34245.77.127.6187.1106.061.596.1NRLow-fat veganOmnivorousMigraine[^3]

### Pooled effects of vegetarian diets on plasma lipids.

In the observational studies, consumption of vegetarian diets was associated with lower mean concentrations of TC (−29.2 mg/dL; 95%CI, −34.6, −23.8; *P* \< 0.001; *I^2^* = 81.4; *P* for heterogeneity \< 0.001); LDL-C (−22.9 mg/dL; 95%CI, −27.9, −17.9; *P* \< 0.001; *I^2^* = 83.3; *P* for heterogeneity \< 0.001); HDL-C (−3.6 mg/dL; 95%CI, −4.7, −2.5; *P* \< 0.001; *I^2^* = 49.7; *P* for heterogeneity \< 0.001); and triglycerides (−6.5 mg/dL; 95%CI, −14.0, 1.1; *P* = 0.092; *I^2^* = 83.0; *P* for heterogeneity \< 0.001) compared with consumption of omnivorous diets ([Figure 2A](#nux030-F2){ref-type="fig"}[--D](#nux030-F3){ref-type="fig"}).

![**Pooled plasma lipid responses to vegetarian diets in observational studies.** Effects on (**A**) TC (total cholesterol), (**B**) LDL-C (low-density lipoprotein cholesterol),](nux030f2ab){#nux030-F2}

![(**C**) HDL-C (high-density lipoprotein cholesterol), and (**D**) triglycerides are depicted as squares; error bars indicate 95%CIs. Meta-analysis yielded pooled estimates of TC (−29.2 mg/dL; 95%CI, −34.6, −23.8; *P* \< 0.001); LDL (−22.9 mg/dL; 95%CI, −27.9, −17.9; *P* \< 0.001); HDL-C (−3.6 mg/dL; 95%CI, −4.7, −2.5; *P* \< 0.001); and triglycerides (−6.5 mg/dL; 95%CI, −14.0, 1.1; *P* = 0.092), which are depicted as black diamonds. Vegan diets were defined as those that omitted all animal products; vegetarian diets may include some animal products, as indicated by the terms lacto (dairy products), ovo (eggs), and pesco (fish). Reference numbers of studies are shown in parentheses.](nux030f2cd){#nux030-F4}

In the clinical trials, consumption of vegetarian diets was associated with a mean reduction in TC (−12.5 mg/dL; 95%CI, −17.8, −7.2; *P* \< 0.001; *I^2^* = 54.8; *P* for heterogeneity = 0.003); LDL-C (−12.2 mg/dL; 95%CI, −17.7, −6.7; *P* \< 0.001; *I^2^* = 79.2; *P* for heterogeneity \< 0.001); and HDL-C (−3.4 mg/dL; 95%CI, −4.3, −2.5; *P* \< 0.001; *I^2^* = 8.5; *P* for heterogeneity = 0.354) and a nonsignificant increase in triglyceride concentration (5.8 mg/dL; 95%CI, −0.9, 12.6; *P* = 0.090; *I^2^* = 22.5; *P* for heterogeneity = 0.182), compared with consumption of omnivorous diets ([Figure 3A](#nux030-F4){ref-type="fig"}[--D](#nux030-F5){ref-type="fig"}).

![**Pooled plasma lipid responses to vegetarian diets in clinical trials.** Effects on (**A**) TC (total cholesterol), (**B**) LDL-C (low-density lipoprotein cholesterol),](nux030f3ab){#nux030-F5}

![(**C**) HDL-C (high-density lipoprotein cholesterol), and (**D**) triglycerides are depicted as squares; error bars indicate 95%CIs. Meta-analysis yielded pooled estimates of TC (−12.5 mg/dL; 95%CI, −17.8, −7.2; *P* \< 0.001); LDL-C (−12.2 mg/dL; 95%CI, −17.7, −6.7; *P* \< 0.001); HDL-C (−3.4 mg/dL; 95%CI, −4.3, −2.5; *P* \< 0.001); and triglycerides (5.8 mg/dL; 95%CI, −0.9, 12.6; *P* = 0.090), which are depicted as black diamonds. Vegan diets were defined as those that omitted all animal products; vegetarian diets may include some animal products, as indicated by the terms lacto (dairy products) and ovo (eggs). Reference numbers of studies are shown in parentheses.](nux030f3cd){#nux030-F3}

### Subgroup analysis and meta-regression.

Pooled changes in plasma lipids associated with consumption of vegetarian diets in planned strata for observational studies and clinical trials are summarized in [Tables S2](#sup1){ref-type="supplementary-material"} and [S3](#sup1){ref-type="supplementary-material"} in the Supporting Information online.

In observational studies, heterogeneity was statistically significant for TC, LDL-C, HDL-C, and triglycerides. Subgroup analysis in observational studies revealed that vegetarian effect size for TC and LDL-C was statistically larger with vegan than with lacto-ovo vegetarian diets; in studies conducted in North or South America; and in younger age groups (\< 50 vs \> 50 years). Moreover, LDL-C concentrations were lower in studies with smaller sample sizes (\< 100). Meta-regression in observational studies also revealed that younger age was associated with lower values for TC (0.44, *P* \< 0.001) and LDL-C (0.31, *P* = 0.002). In addition, TC and LDL-C in vegetarian groups were lower in studies with smaller sample sizes (slope 0.006, *P* \< 0.001 for TC; slope 0.006, *P* \< 0.001 for LDL-C), larger percentages of male participants (slope −0.14, *P* \< 0.001; slope −0.11, *P* \< 0.001), and lower overall mean plasma lipids for all participants, vegetarian and nonvegetarian (slope 0.41, *P* \< 0.001 for TC; slope 0.30, *P* \< 0.001 for LDL-C).

In clinical trials, the reductions of TC and LDL-C were greater in the BMI subgroup 18.5 to 25 kg/m^2^ than in other subgroups. Meta-regression also revealed that smaller BMI was associated with larger TC (slope 1.49, *P* \< 0.001) or LDL-C (slope 1.02, *P* \< 0.001) reductions with vegetarian diets. Participants who did not use lipid-lowering medication showed larger reductions in TC and LDL-C than participants who used them. Vegan diets were associated with larger LDL-C reductions than lacto-ovo vegetarian diets. Smaller sample size was associated with greater LDL-C reductions in the subgroup analysis and greater reductions of both TC and LDL-C in meta-regression analysis (slope 0.03, *P* = 0.050; and slope 0.03, *P* = 0.015, respectively).

### Sensitivity analysis.

In the 1-study removed analysis, results were largely unchanged, with plasma lipid differences between vegetarian and comparison groups ranging from −30.0 to −28.0 mg/dL for TC and from −23.74 to −21.96 mg/dL for LDL-C in observational studies (*P* \< 0.001 in all cases) and from −13.5 to −10.4 mg/dL for TC and from −13.2 to −9.2 mg/dL for LDL-C in clinical trials (all results were *P* \< 0.001).

### Publication bias.

Funnel plot outcomes revealed that larger trials reporting large reductions in TC were possibly overrepresented in observational studies. A few studies showing a smaller effect size were absent in the middle right side (see [Figure S1A](#sup1){ref-type="supplementary-material"} in the Supporting Information online). Egger's test could not confirm this impression (*P* = 0.133). Trim-and-fill method outcomes suggested that 7 studies were missing, and their addition would have changed the overall effect on TC to −23.8 mg/dL (95%CI, −29.6, −18.0).

Funnel plot outcomes for the clinical trials suggested that smaller trials that reported large reductions in TC were overrepresented (see [Figure S1B](#sup1){ref-type="supplementary-material"} in the Supporting Information online). If publication bias did not exist, study results would be symmetrically displayed about the mean effect size; studies showing smaller lipid reductions were missing in the bottom right side. Egger's test could not confirm this impression (*P* = 0.069). Trim-and-fill method outcomes suggested that 4 trials might have been missing, and their addition would have changed the overall effect on TC from −12.5 mg/dL to −8.57 mg/dL (95%CI, −14.79, −2.35).

DISCUSSION
==========

This meta-analysis of 30 observational studies and 19 controlled trials shows that, compared with consumption of omnivorous diets, consumption of vegetarian diets is associated with lower TC, LDL-C, and HDL-C concentrations but not with differences in triglyceride concentrations. The meta-analysis shows overall differences in TC of −29.2 mg/dL in observational studies and −12.5 mg/dL in clinical trials and differences in LDL-C of −22.9 mg/dL in observational studies and −12.2 mg/dL in clinical trials. High-density lipoprotein cholesterol was also lower in vegetarian groups than in omnivorous groups, although the degree of difference was relatively modest (−3.6 mg/dL in observational studies and −3.4 mg/dL in clinical trials). Subgroup analysis indicated that younger age (\< 50 years), male sex, lower baseline plasma lipids, and lower BMI were associated with greater reductions in TC and LDL-C.

The findings of the current study are consistent with those of previous reviews,[@nux030-B6]^,^[@nux030-B7] and the present analysis extends these findings to include a meta-analysis of observational study data. While observational studies present a higher risk of bias compared with clinical trials, they also reflect long-term effects of vegetarian diets on plasma lipids that are not apparent in most clinical trials. Those who have followed vegetarian dietary patterns for longer periods may have healthier body compositions as well as better adherence to a vegetarian diet, both of which may have an effect on blood lipids. In addition, this study presents the raw mean difference for each endpoint, which is useful when the measure is meaningful either inherently or because of widespread use.[@nux030-B59]

For context, a previous meta-analysis showed that, on average, statin use reduced LDL-C concentrations by 70 mg/dL (1.8 mmol), with considerable variation depending on statin type.[@nux030-B60] The results of the present analysis showed that diet alone reduced LDL-C by 22.9 mg/dL in observational studies and by 12.2 mg/dL in clinical trials. While dietary changes may not be as powerful as statins in reducing plasma lipids, dietary and pharmacologic interventions are not mutually exclusive. They can work together, and, in some cases, dietary practices can obviate the need for medications. Because side effects may interfere with medication compliance and may preclude statin use for certain patients, dietary options have some intrinsic advantages.

Vegetarian diets are typically lower in saturated fatty acids and cholesterol, compared with omnivorous diets. In 3 large cohort studies that included large numbers of vegetarian participants (Adventist Health Study 2 cohort, European Prospective Investigation into Cancer and Nutrition (EPIC)-Oxford study, and UK Women's Study), intakes of saturated fatty acid and cholesterol were lower in vegetarians than in omnivorous participants, with strict vegetarians having the lowest intakes of both.[@nux030-B61] The subgroup analysis in the present study showed that a vegan diet had larger effects on plasma lipids than a lacto-ovo vegetarian diet. The observed effects of plant-based diets on plasma lipids are likely to be, in large part, the result of differences in saturated fatty acid intake and, to a lesser extent, cholesterol intake.[@nux030-B62]^,^[@nux030-B63] The role of saturated fat intake in cardiovascular outcomes has been questioned recently, in part due to heterogeneity in meta-analyses.[@nux030-B64] This issue is beyond the scope of the present article, which is limited to the effect of diet on blood lipid concentrations.

The effects of changes in dietary cholesterol on serum cholesterol decline as baseline dietary cholesterol increases.[@nux030-B65] Hopkins's analysis indicated that hepatic cholesterol overload may be the primary basis for the observed weak response to increasing dietary cholesterol in the context of a high baseline concentration.[@nux030-B65] However, according to the subgroup analysis in the present study, a lower baseline plasma lipid concentration was related to a greater reduction of TC and LDL-C in plasma by vegetarian diets in clinical trials.

This meta-regression and subgroup analysis showed that the duration of adherence to a vegetarian diet did not modulate the observed effects of the diet. However, younger age was associated with lower TC and LDL-C, suggesting that an effect of diet duration may play a role. Additionally, the present analysis could not adjust for dietary compliance. Further studies are needed to clarify the relation between the duration of vegetarian diets and its effect on plasma lipids.

In this study, HDL-C concentrations were also significantly lower in the context of vegetarian diets than in omnivorous diets. Although some studies have suggested that HDL-C concentrations are inversely associated with coronary heart disease,[@nux030-B66] recent studies have shown that interventions that increase HDL-C do not reduce the risk of coronary heart disease[@nux030-B67] and that genetic variants that raise HDL-C do not necessarily reduce the risk of coronary heart disease.[@nux030-B68]

Due to their range of health benefits, vegetarian diets are specifically mentioned in the *2015--2020 Dietary Guidelines for Americans*[@nux030-B69] as 1 of 3 noteworthy healthful diet patterns. As demonstrated in this study, improved lipid profiles are among these benefits. Moreover, the range of plant-derived foods is enormous, including simple fruits, vegetables, beans, and whole grains as well as products that are processed and prepared with a variety of additional ingredients. The lipid-lowering effect of a plant-based diet can be maximized by selection of specific foods. In a randomized trial of a so-called portfolio diet that included foods rich in soluble fiber, soy protein, plant sterols, and almonds, an LDL-C reduction of 28.6% was observed in 4 weeks.[@nux030-B70] The strengths of the present meta-analysis include a substantial sample size that lends confidence to these findings and allowed subgroup analyses in specific population groups. In addition, the focus of the meta-analysis on food consumption as opposed to supplements or other artificial interventions makes the findings applicable to the public.

An important limitation is heterogeneity. Meta-regression and subgroup analyses showed that sex, age, baseline plasma lipids, type of vegetarian diets, sample size, and BMI may be key reasons for this heterogeneity. Still, lower TC and LDL-C concentrations were seen in all subgroups. In addition, all observational studies used cross-sectional rather than prospective designs, a limitation that is somewhat alleviated by the inclusion of randomized clinical trials. Lastly, although all observational studies included in this study adjusted for age and sex, some did not adjust for other possible confounders such as BMI or physical activity level. Further studies are needed to explore the possible mechanisms by which vegetarian diets influence plasma lipids. The results of this meta-analysis suggest a strong association between consumption of vegetarian diets and lower plasma lipid concentrations.

CONCLUSION
==========

Consumption of vegetarian diets, particularly vegan diets, is associated with lower levels of plasma lipids, which could offer individuals and healthcare professionals an effective option for reducing the risk of heart disease or other chronic conditions. Although not all clinicians have the training or time to confidently guide patients toward healthful vegetarian diets, registered dietitians can provide the services necessary to assist patients in making this transition.
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